- Home >
- News, events and blog >
HSSIB identifies inequitable support for people with a learning disability to safely self-administer insulin
...not been adequately supported to self-administer insulin safely.
Showing results 11 - 20 from a total of 34
- Home >
- Patient safety investigations >
- Insulin: supporting safe self-administration in vulnerable patient groups in the community >
Insulin: supporting safe self-administration for patients in the community with a mental health problem
Insulin...
- Home >
- News, events and blog >
Life-threatening gaps in community support for people with disabilities managing insulin
The patient required insulin for their diabetes and had been self-administering. However, due to a trapped nerve they had recently been unable to administer their insulin.
- Home >
- Patient safety investigations >
- Medication related harm >
Medication not given: discharge from an acute hospital to the community
NHS (2023) Insulin for type 2 diabetes. Available at https://www.nhs.uk/medicines/insulin/insulin-for-type-2-diabetes/ (Accessed 2 June 2025).
- Home >
- News, events and blog >
Disconnect in specialist diabetes care for adults with mental health problems
From a staff perspective, a patient experiencing a mental health problem with access to insulin was described as a “huge red flag”.
- Home >
- Safety Recommendations Log >
Insulin: supporting safe self-administration in vulnerable patient groups in the community
- Home >
- Safety Recommendations Log >
Insulin: supporting safe self-administration in vulnerable patient groups in the community
- Home >
- Safety Recommendations Log >
Insulin: supporting safe self-administration in vulnerable patient groups in the community
- Home >
- News, events and blog >
Report emphasises importance of clear information to support safe and timely medication administration post hospital discharge
In this case, the patient’s emergency readmission after not taking his insulin shows the real potential for harm when these systems don’t work as intended.
- Home >
- Patient safety investigations >
- Never events: analysis of HSIB's national investigations >
Never events: analysis of HSIB’s national investigations
She had insulin-treated type 2 diabetes and required high-dose insulin (500 units per ml) from an insulin pen device.